Industry: Chemical & Material
Published Date: 2026-03-09
Pages: 83 Pages
Report ld: 6087157
Request Sample
Customized Report
Pharmaceutical-grade HFA-134a Market Size(US$)

CAGR 2026-2032
7.1%
Market Size,2032
USD 1,400
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Pharmaceutical-grade HFA-134a was estimated to be worth US$ 872 million in 2025 and is projected to reach US$ 1400 million, growing at a CAGR of 7.1% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Pharmaceutical-grade HFA-134a cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Pharmaceutical grade HFA-134a (1,1,1,2-tetrafluoroethane) is a high-purity aerosol propellant specifically designed for inhaled drug delivery systems (such as metered-dose inhalers for the treatment of asthma and chronic obstructive pulmonary disease). Its purity must comply with the standards of the United States Pharmacopoeia (USP) or the European Pharmacopoeia (EP), usually requiring ≥99.97%, and strictly controlling moisture, acidic impurities and non-volatile residues to ensure safety and compatibility. As an ozone-friendly alternative, it has gradually replaced traditional CFC propellants.
The North American market for Pharmaceutical-grade HFA-134a was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Pharmaceutical-grade HFA-134a was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Pharmaceutical-grade HFA-134a was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Pharmaceutical-grade HFA-134a market include SRF, Koura, Juhua shares, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Pharmaceutical-grade HFA-134a, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Pharmaceutical-grade HFA-134a market size, estimations, and forecasts are presented in terms of sales volume (kg) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Pharmaceutical-grade HFA-134a.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Pharmaceutical-grade HFA-134a manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Pharmaceutical-grade HFA-134a sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Pharmaceutical-grade HFA-134a sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Pharmaceutical-grade HFA-134a Product Introduction
1.2 Global Pharmaceutical-grade HFA-134a Market Size Forecast
1.2.1 Global Pharmaceutical-grade HFA-134a Sales Value (2021–2032)
1.2.2 Global Pharmaceutical-grade HFA-134a Sales Volume (2021–2032)
1.2.3 Global Pharmaceutical-grade HFA-134a Sales Price (2021–2032)
1.3 Pharmaceutical-grade HFA-134a Market Trends & Drivers
1.3.1 Pharmaceutical-grade HFA-134a Industry Trends
1.3.2 Pharmaceutical-grade HFA-134a Market Drivers & Opportunities
1.3.3 Pharmaceutical-grade HFA-134a Market Challenges
1.3.4 Pharmaceutical-grade HFA-134a Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Pharmaceutical-grade HFA-134a Players Revenue Ranking (2025)
2.2 Global Pharmaceutical-grade HFA-134a Revenue by Company (2021–2026)
2.3 Global Pharmaceutical-grade HFA-134a Sales Volume Ranking of Players (2025)
2.4 Global Pharmaceutical-grade HFA-134a Sales Volume by Company (2021–2026)
2.5 Global Pharmaceutical-grade HFA-134a Average Price by Company (2021–2026)
2.6 Key Manufacturers Pharmaceutical-grade HFA-134a Manufacturing Base and Headquarters
2.7 Key Manufacturers Pharmaceutical-grade HFA-134a Product Offerings
2.8 Key Manufacturers Start of Mass Production of Pharmaceutical-grade HFA-134a
2.9 Pharmaceutical-grade HFA-134a Market Competitive Analysis
2.9.1 Pharmaceutical-grade HFA-134a Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Pharmaceutical-grade HFA-134a Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pharmaceutical-grade HFA-134a revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Pharmaceutical-grade HFA-134a Market Classification
3.1 Introduction by Type
3.1.1 99.99%
3.1.2 >99.99%
3.1.3 Global Pharmaceutical-grade HFA-134a Sales Value by Type
3.1.3.1 Global Pharmaceutical-grade HFA-134a Sales Value by Type (2021 vs 2025 vs 2032)
3.1.3.2 Global Pharmaceutical-grade HFA-134a Sales Value, by Type (2021–2032)
3.1.3.3 Global Pharmaceutical-grade HFA-134a Sales Value, by Type (%), 2021–2032
3.1.4 Global Pharmaceutical-grade HFA-134a Sales Volume by Type
3.1.4.1 Global Pharmaceutical-grade HFA-134a Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Pharmaceutical-grade HFA-134a Sales Volume, by Type (2021–2032)
3.1.4.3 Global Pharmaceutical-grade HFA-134a Sales Volume, by Type (%), 2021–2032
3.1.5 Global Pharmaceutical-grade HFA-134a Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Inhalation Aerosols
4.1.2 Topical Sprays
4.1.3 Others
4.2 Global Pharmaceutical-grade HFA-134a Sales Value by Application
4.2.1 Global Pharmaceutical-grade HFA-134a Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Pharmaceutical-grade HFA-134a Sales Value, by Application (2021–2032)
4.2.3 Global Pharmaceutical-grade HFA-134a Sales Value, by Application (%), 2021–2032
4.3 Global Pharmaceutical-grade HFA-134a Sales Volume by Application
4.3.1 Global Pharmaceutical-grade HFA-134a Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Pharmaceutical-grade HFA-134a Sales Volume, by Application (2021–2032)
4.3.3 Global Pharmaceutical-grade HFA-134a Sales Volume, by Application (%), 2021–2032
4.4 Global Pharmaceutical-grade HFA-134a Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Pharmaceutical-grade HFA-134a Sales Value by Region
5.1.1 Global Pharmaceutical-grade HFA-134a Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Pharmaceutical-grade HFA-134a Sales Value by Region (2021–2026)
5.1.3 Global Pharmaceutical-grade HFA-134a Sales Value by Region (2027–2032)
5.1.4 Global Pharmaceutical-grade HFA-134a Sales Value by Region (%), 2021–2032
5.2 Global Pharmaceutical-grade HFA-134a Sales Volume by Region
5.2.1 Global Pharmaceutical-grade HFA-134a Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Pharmaceutical-grade HFA-134a Sales Volume by Region (2021–2026)
5.2.3 Global Pharmaceutical-grade HFA-134a Sales Volume by Region (2027–2032)
5.2.4 Global Pharmaceutical-grade HFA-134a Sales Volume by Region (%), 2021–2032
5.3 Global Pharmaceutical-grade HFA-134a Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Pharmaceutical-grade HFA-134a Sales Value, 2021–2032
5.4.2 North America Pharmaceutical-grade HFA-134a Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Pharmaceutical-grade HFA-134a Sales Value, 2021–2032
5.5.2 Europe Pharmaceutical-grade HFA-134a Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Pharmaceutical-grade HFA-134a Sales Value, 2021–2032
5.6.2 Asia Pacific Pharmaceutical-grade HFA-134a Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Pharmaceutical-grade HFA-134a Sales Value, 2021–2032
5.7.2 South America Pharmaceutical-grade HFA-134a Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Pharmaceutical-grade HFA-134a Sales Value, 2021–2032
5.8.2 Middle East & Africa Pharmaceutical-grade HFA-134a Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Pharmaceutical-grade HFA-134a Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Pharmaceutical-grade HFA-134a Sales Value and Sales Volume
6.2.1 Key Countries/Regions Pharmaceutical-grade HFA-134a Sales Value, 2021–2032
6.2.2 Key Countries/Regions Pharmaceutical-grade HFA-134a Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Pharmaceutical-grade HFA-134a Sales Value, 2021–2032
6.3.2 United States Pharmaceutical-grade HFA-134a Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Pharmaceutical-grade HFA-134a Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Pharmaceutical-grade HFA-134a Sales Value, 2021–2032
6.4.2 Europe Pharmaceutical-grade HFA-134a Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Pharmaceutical-grade HFA-134a Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Pharmaceutical-grade HFA-134a Sales Value, 2021–2032
6.5.2 China Pharmaceutical-grade HFA-134a Sales Value by Type (%), 2025 vs 2032
6.5.3 China Pharmaceutical-grade HFA-134a Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Pharmaceutical-grade HFA-134a Sales Value, 2021–2032
6.6.2 Japan Pharmaceutical-grade HFA-134a Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Pharmaceutical-grade HFA-134a Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Pharmaceutical-grade HFA-134a Sales Value, 2021–2032
6.7.2 South Korea Pharmaceutical-grade HFA-134a Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Pharmaceutical-grade HFA-134a Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Pharmaceutical-grade HFA-134a Sales Value, 2021–2032
6.8.2 Southeast Asia Pharmaceutical-grade HFA-134a Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Pharmaceutical-grade HFA-134a Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Pharmaceutical-grade HFA-134a Sales Value, 2021–2032
6.9.2 India Pharmaceutical-grade HFA-134a Sales Value by Type (%), 2025 vs 2032
6.9.3 India Pharmaceutical-grade HFA-134a Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 SRF
7.1.1 SRF Company Information
7.1.2 SRF Introduction and Business Overview
7.1.3 SRF Pharmaceutical-grade HFA-134a Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 SRF Pharmaceutical-grade HFA-134a Product Offerings
7.1.5 SRF Recent Developments
7.2 Koura
7.2.1 Koura Company Information
7.2.2 Koura Introduction and Business Overview
7.2.3 Koura Pharmaceutical-grade HFA-134a Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Koura Pharmaceutical-grade HFA-134a Product Offerings
7.2.5 Koura Recent Developments
7.3 Juhua shares
7.3.1 Juhua shares Company Information
7.3.2 Juhua shares Introduction and Business Overview
7.3.3 Juhua shares Pharmaceutical-grade HFA-134a Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Juhua shares Pharmaceutical-grade HFA-134a Product Offerings
7.3.5 Juhua shares Recent Developments
8 Industry Chain Analysis
8.1 Pharmaceutical-grade HFA-134a Industrial Chain
8.2 Pharmaceutical-grade HFA-134a Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Pharmaceutical-grade HFA-134a Sales Model
8.5.2 Sales Channels
8.5.3 Pharmaceutical-grade HFA-134a Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Pharmaceutical-grade HFA-134a market is projected to grow from US$ 872 million in 2025 to US$ 1400 million by 2032, at a CAGR of 7.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-12
Pages: 121
USD 4900.00
(Single User License)
The global Pharmaceutical-grade HFA-134a market size was US$ 872 million in 2025 and is forecast to reach a readjusted size of US$ 1400 million by 2032 with a CAGR of 7.1% during the forecast period 2026-2032.
Published Date: 2026-03-12
Pages: 72
USD 4250.00
(Single User License)
The global Pharmaceutical-grade HFA-134a market was valued at US$ 872 million in 2025 and is anticipated to reach US$ 1400 million by 2032, at a CAGR of 7.1% from 2026 to 2032.
Published Date: 2026-03-12
Pages: 125
USD 2900.00
(Single User License)
The global market for Pharmaceutical-grade HFA-134a was valued at US$ 823 million in the year 2024 and is projected to reach a revised size of US$ 1316 million by 2031, growing at a CAGR of 7.1% during the forecast period.
Published Date: 2025-06-19
Pages: 80
USD 2900.00
(Single User License)
The global market for Pharmaceutical-grade HFA-134a was estimated to be worth US$ 823 million in 2024 and is forecast to a readjusted size of US$ 1316 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.
Published Date: 2025-06-19
Pages: 85
USD 3950.00
(Single User License)
The global Pharmaceutical-grade HFA-134a market size was US$ 823 million in 2024 and is forecast to a readjusted size of US$ 1316 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.
Published Date: 2025-06-19
Pages: 69
USD 4250.00
(Single User License)
The global Pharmaceutical-grade HFA-134a market is projected to grow from US$ 872 million in 2025 to US$ 1316 million by 2031, at a Compound Annual Growth Rate (CAGR) of 7.1% during the forecast period.
Published Date: 2025-06-19
Pages: 116
USD 4900.00
(Single User License)
The global Pharmaceutical-grade HFA-134a market is projected to grow from US$ 872 million in 2025 to US$ 1400 million by 2032, at a CAGR of 7.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-12
Pages: 121
The global Pharmaceutical-grade HFA-134a market size was US$ 872 million in 2025 and is forecast to reach a readjusted size of US$ 1400 million by 2032 with a CAGR of 7.1% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 72
The global Pharmaceutical-grade HFA-134a market was valued at US$ 872 million in 2025 and is anticipated to reach US$ 1400 million by 2032, at a CAGR of 7.1% from 2026 to 2032.
Published: 2026-03-12
Pages: 125
The global market for Pharmaceutical-grade HFA-134a was valued at US$ 823 million in the year 2024 and is projected to reach a revised size of US$ 1316 million by 2031, growing at a CAGR of 7.1% during the forecast period.
Published: 2025-06-19
Pages: 80
The global market for Pharmaceutical-grade HFA-134a was estimated to be worth US$ 823 million in 2024 and is forecast to a readjusted size of US$ 1316 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.
Published: 2025-06-19
Pages: 85
The global Pharmaceutical-grade HFA-134a market size was US$ 823 million in 2024 and is forecast to a readjusted size of US$ 1316 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.
Published: 2025-06-19
Pages: 69
The global Pharmaceutical-grade HFA-134a market is projected to grow from US$ 872 million in 2025 to US$ 1316 million by 2031, at a Compound Annual Growth Rate (CAGR) of 7.1% during the forecast period.
Published: 2025-06-19
Pages: 116
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now